Loading...
Shin-Etsu Chemical Co., Ltd.
SHECY•PNK
Basic Materials
Chemicals
$14.40
$-0.01(-0.07%)
Shin-Etsu Chemical Co., Ltd. (SHECY) Financial Performance & Income Statement Overview
Review Shin-Etsu Chemical Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.06%
↑ 6.06%
Operating Income Growth
5.86%
↑ 5.86%
Net Income Growth
2.67%
↑ 2.67%
Operating Cash Flow Growth
16.78%
↑ 16.78%
Operating Margin
28.97%
↑ 28.97%
Gross Margin
38.42%
↑ 38.42%
Net Profit Margin
20.85%
↑ 20.85%
ROE
11.72%
↑ 11.72%
ROIC
14.55%
↑ 14.55%
Shin-Etsu Chemical Co., Ltd. (SHECY) Income Statement & Financial Overview
Review Shin-Etsu Chemical Co., Ltd.'s (SHECY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $631.55B | $663.24B | $668.53B | $597.93B |
| Cost of Revenue | $406.75B | $422.90B | $392.14B | $355.34B |
| Gross Profit | $224.81B | $240.34B | $276.39B | $242.59B |
| Gross Profit Ratio | $0.36 | $0.36 | $0.41 | $0.41 |
| R&D Expenses | $21.60B | $17.70B | $16.90B | $16.90B |
| SG&A Expenses | $45.54B | $61.60B | $44.81B | $51.57B |
| Operating Expenses | $67.14B | $61.60B | $61.71B | $51.57B |
| Total Costs & Expenses | $473.88B | $484.50B | $453.85B | $406.91B |
| Interest Income | $20.86B | $21.33B | $23.26B | $21.28B |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $65.98B | $63.88B | $56.52B | $52.00B |
| EBITDA | $235.94B | $242.61B | $286.02B | $272.77B |
| EBITDA Ratio | $0.37 | $0.37 | $0.43 | $0.46 |
| Operating Income | $157.67B | $178.74B | $214.68B | $191.02B |
| Operating Income Ratio | $0.25 | $0.27 | $0.32 | $0.32 |
| Other Income/Expenses (Net) | $8.07B | $31.50B | $14.81B | $29.74B |
| Income Before Tax | $165.74B | $210.24B | $229.49B | $220.76B |
| Income Before Tax Ratio | $0.26 | $0.32 | $0.34 | $0.37 |
| Income Tax Expense | $54.28B | $59.84B | $65.89B | $66.11B |
| Net Income | $101.48B | $138.42B | $150.10B | $144.02B |
| Net Income Ratio | $0.16 | $0.21 | $0.22 | $0.24 |
| EPS | $51.76 | $69.92 | $75.62 | $72.21 |
| Diluted EPS | $51.76 | $69.84 | $75.62 | $72.13 |
| Weighted Avg Shares Outstanding | $1.96B | $1.98B | $1.98B | $2.00B |
| Weighted Avg Shares Outstanding (Diluted) | $1.96B | $1.98B | $1.98B | $2.00B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan